SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-002701
Filing Date
2024-01-17
Accepted
2024-01-17 16:05:30
Documents
13
Period of Report
2024-01-11
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 40680
  Complete submission text file 0001493152-24-002701.txt   258597

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE ocea-20240111.xsd EX-101.SCH 3509
3 XBRL DEFINITION FILE ocea-20240111_def.xml EX-101.DEF 26524
4 XBRL LABEL FILE ocea-20240111_lab.xml EX-101.LAB 36433
5 XBRL PRESENTATION FILE ocea-20240111_pre.xml EX-101.PRE 25148
7 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5097
Mailing Address 515 MADISON AVE SUITE 8078 NEW YORK NY 10022
Business Address 515 MADISON AVE SUITE 8078 NEW YORK NY 10022 (646) 908-2658
Ocean Biomedical, Inc. (Filer) CIK: 0001869974 (see all company filings)

IRS No.: 871309280 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40793 | Film No.: 24538446
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)